Cargando…
The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
Several reports have demonstrated a role for aberrant NOTCH signaling in melanoma genesis and progression, prompting us to explore if targeting this pathway is a valid therapeutic approach against melanoma. We targeted NOTCH signaling using RO4929097, a novel inhibitor of gamma secretase, which is a...
Autores principales: | Huynh, Chanh, Poliseno, Laura, Segura, Miguel F., Medicherla, Ratna, Haimovic, Adele, Menendez, Silvia, Shang, Shulian, Pavlick, Anna, Shao, Yongzhao, Darvishian, Farbod, Boylan, John F., Osman, Iman, Hernando, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182998/ https://www.ncbi.nlm.nih.gov/pubmed/21980408 http://dx.doi.org/10.1371/journal.pone.0025264 |
Ejemplares similares
-
Correction: The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011) -
Deletion of PTENP1 pseudogene in human melanoma
por: Poliseno, Laura, et al.
Publicado: (2011) -
Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by γ-Secretase Inhibitor RO4929097
por: Wang, Lu, et al.
Publicado: (2018) -
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
por: Diaz-Padilla, Ivan, et al.
Publicado: (2013) -
γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression
por: Chang, Shun-Fu, et al.
Publicado: (2021)